Y. C. Foong Et Al. , "Comparing ocrelizumab to interferon/glatiramer acetate in people with multiple sclerosis over age 60," Journal of Neurology, Neurosurgery and Psychiatry , 2024
Foong, Y. C. Et Al. 2024. Comparing ocrelizumab to interferon/glatiramer acetate in people with multiple sclerosis over age 60. Journal of Neurology, Neurosurgery and Psychiatry .
Foong, Y. C., Merlo, D., Gresle, M., Buzzard, K., Zhong, M., Yeh, W. Z., ... Jokubaitis, V.(2024). Comparing ocrelizumab to interferon/glatiramer acetate in people with multiple sclerosis over age 60. Journal of Neurology, Neurosurgery and Psychiatry .
Foong, Yi Et Al. "Comparing ocrelizumab to interferon/glatiramer acetate in people with multiple sclerosis over age 60," Journal of Neurology, Neurosurgery and Psychiatry , 2024
Foong, Yi C. Et Al. "Comparing ocrelizumab to interferon/glatiramer acetate in people with multiple sclerosis over age 60." Journal of Neurology, Neurosurgery and Psychiatry , 2024
Foong, Y. C. Et Al. (2024) . "Comparing ocrelizumab to interferon/glatiramer acetate in people with multiple sclerosis over age 60." Journal of Neurology, Neurosurgery and Psychiatry .
@article{article, author={Yi Chao Foong Et Al. }, title={Comparing ocrelizumab to interferon/glatiramer acetate in people with multiple sclerosis over age 60}, journal={Journal of Neurology, Neurosurgery and Psychiatry}, year=2024}